Drugs / Adipose Tissue derived Total-Stromal-Cells
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT05280002 | Jan 2018 → Oct 2021 | osteoarthritis, knee | Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh | Completed | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Adipose Tissue derived Total-Stromal-Cells | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05280002 ↗ |
| Known as | TOST | “Adipose Tissue derived Total-Stromal-Cells (TOST)” NCT05280002 ↗ |
| Modality | Cell therapy | “Adipose Tissue derived Total-Stromal-Cells (TOST) containing mesenchymal stem cells” NCT05280002 ↗ |
| Route | Other | “single intra-articular (IA) injection” NCT05280002 ↗ |